COMMUNIQUÉS West-GlobeNewswire

LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025
29/10/2025
SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1. [...]
Immutep Quarterly Activities Report Q1 FY26
29/10/2025
Media Release Pivotal TACTI-004 (KEYNOTE-F91) Phase III trial evaluating eftilagimod alfa (efti) in first line non-small cell lung cancer continues to build momentum and is recruiting patients at a growing number of [...]
LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3
29/10/2025
BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT, LIXTW), a clinical-stage pharmaceutical company advancing LB-100, a first-in-class [...]
OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
29/10/2025
Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance WESTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- [...]
Hyperion DeFi Announces Strategic Partnership with Felix to Launch HIP-3 Powered Perpetual Futures Market
29/10/2025
New Hyperliquid Product Compounds Yield on 500,000 HYPE Staked by the Company LAGUNA HILLS, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S [...]
Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference
29/10/2025
CELEBRATION, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, [...]
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group
29/10/2025
ADAS-Cog13 difference −12.78 (P < 0.0001) with oral blarcamesine treatment compared to ADNI control group at Week 144 77.4 Weeks (17.8 Months) ‘time saved’ with oral blarcamesine compared to ADNI Restoring impaired [...]
Aclaris Therapeutics to Participate in Three November Healthcare Conferences
29/10/2025
WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
29/10/2025
BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business [...]
Vireo Growth Inc. and Verano Holdings Corp. Announce Resolution of Litigation Matters
29/10/2025
CHICAGO and MINNEAPOLIS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) and Verano Holdings Corp. (“Verano”, Vireo and Verano, each a “Company”) (Cboe CA: VRNO) (OTCQX: VRNOF) [...]
Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management
29/10/2025
SHANGHAI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun [...]
CMR Surgical Adopts NVIDIA IGX THOR for AI-Powered, Next Generation Surgical Robotics
29/10/2025
CMR Surgical Adopts NVIDIA IGX THOR for AI-Powered, Next Generation Surgical Robotics ● Testing to focus on the potential to deliver real-time, AI-powered insights that improve patient outcomes and support continuous [...]
Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients
29/10/2025
October 29, 2025 3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant difference in major [...]
Grâce à l’intégration de l’IA, mediCAD® 8 transforme la planification préopératoire en orthopédie et traumatologie
29/10/2025
LANDSHUT, Allemagne, 29 oct. 2025 (GLOBE NEWSWIRE) -- La dernière version de mediCAD® 8 publiée par mediCAD Hectec GmbH marque une nouvelle ère dans la planification intelligente en orthopédie et traumatologie. En [...]
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
29/10/2025
New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helps clinicians confidently distinguish dengue from other acute fever-causing [...]
Addex Increases Issued Share Capital to Create Treasury Shares
29/10/2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, October 29, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel [...]
Bio Usawa Takes Strategic Step into Europe with New Subsidiary in Frankfurt, Germany
29/10/2025
KIGALI, Rwanda and FRANKFURT, Germany and SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd (Rwanda) proudly announces the establishment of its new European subsidiary, Bio Usawa Biotech [...]
14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge
29/10/2025
Young innovators recognized with $100K for STEM research advancing science and tackling global challenges WASHINGTON, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Thermo Fisher Scientific and Society for Science today announced [...]
Canadian Red Cross opens appeal to help people impacted by Hurricane Melissa
28/10/2025
OTTAWA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the Hurricane Melissa Appeal to help those impacted by the hurricane in the Caribbean. The Red Cross is working to get help to people in [...]

Pages